We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$136M
AUM Growth
+$1.33M
Cap. Flow
-$2.17M
Cap. Flow %
-1.59%
Top 10 Hldgs %
21.77%
Holding
187
New
33
Increased
43
Reduced
61
Closed
33

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$1.43M
2
MLM icon
Martin Marietta Materials
MLM
+$1.31M
3
EXPD icon
Expeditors International
EXPD
+$1.16M
4
LPX icon
Louisiana-Pacific
LPX
+$890K
5
CCL icon
Carnival Corporation Ltd
CCL
+$839K

Top Sells

Rank Stock Value
1
PRXL
Parexel International Corp
PRXL
+$2.14M
2
NSC icon
Norfolk Southern
NSC
+$1.25M
3
MS icon
Morgan Stanley
MS
+$1.13M
4
AMGN icon
Amgen
AMGN
+$1,000K
5
TD icon
Toronto Dominion Bank
TD
+$913K

Sector Composition

Rank Sector Weight
1 Industrials 23.47%
2 Healthcare 19.52%
3 Financials 17.24%
4 Consumer Staples 11.65%
5 Technology 11.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVS icon
76
Novartis
NVS
$293B
$683K 0.5%
8,872
-8,147
-48% -$615K
MHK icon
77
Mohawk Industries
MHK
$8.97B
$668K 0.49%
2,700
-125
-4% -$31.1K
PRU icon
78
Prudential Financial
PRU
$41.9B
$652K 0.48%
+6,135
New +$656K
EL icon
79
Estee Lauder
EL
$30.9B
$650K 0.48%
6,025
-850
-12% -$87.2K
CFG icon
80
Citizens Financial Group
CFG
$30.5B
$642K 0.47%
16,950
-3,600
-18% -$126K
HD icon
81
Home Depot
HD
$349B
$642K 0.47%
3,924
+1,158
+42% +$178K
XRAY icon
82
Dentsply Sirona
XRAY
$2.64B
$630K 0.46%
+10,540
New +$627K
AMGN icon
83
Amgen
AMGN
$219B
$616K 0.45%
3,302
-5,643
-63% -$1,000K
POT
84
DELISTED
Potash Corp Of Saskatchewan
POT
$614K 0.45%
31,920
-3,450
-10% -$61.5K
T icon
85
AT&T
T
$162B
$598K 0.44%
20,198
+795
+4% +$22.6K
KO icon
86
Coca-Cola
KO
$374B
$594K 0.44%
13,193
– –
AZN icon
87
AstraZeneca
AZN
$250B
$569K 0.42%
8,404
+4,829
+135% +$305K
CP icon
88
Canadian Pacific Kansas City
CP
$79.3B
$553K 0.41%
16,450
-250
-1% -$7.95K
MCD icon
89
McDonald's
MCD
$196B
$528K 0.39%
3,367
-300
-8% -$47K
GEN icon
90
Gen Digital
GEN
$16.8B
$515K 0.38%
15,700
+3,500
+29% +$107K
XPO icon
91
XPO
XPO
$23B
$512K 0.38%
+21,830
New +$457K
WY icon
92
Weyerhaeuser
WY
$18.3B
$507K 0.37%
14,900
+1,350
+10% +$44.3K
QSR icon
93
Restaurant Brands International
QSR
$25.3B
$503K 0.37%
7,877
– –
MO icon
94
Altria Group
MO
$113B
$442K 0.32%
6,964
-450
-6% -$30K
J icon
95
Jacobs Solutions
J
$16.9B
$429K 0.31%
8,893
-14,984
-63% -$670K
DVN icon
96
Devon Energy
DVN
$49.7B
$423K 0.31%
11,531
-9,950
-46% -$322K
A icon
97
Agilent Technologies
A
$39.9B
$417K 0.31%
6,500
-200
-3% -$12.5K
GSK icon
98
GSK
GSK
$104B
$402K 0.29%
7,925
-120
-1% -$6.09K
NOC icon
99
Northrop Grumman
NOC
$80.7B
$396K 0.29%
1,375
– –
ROL icon
100
Rollins
ROL
$17.7B
$392K 0.29%
19,125
+1,800
+10% +$34.8K
2 3
4
5 6

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return
FAFN
First Affirmative Financial Network Colorado Springs, Colorado $258M AUM

New England Research & Management's Q3 2017 Portfolio in Review

As of Q3 2017, New England Research & Management held 187 positions worth $136M, up 0.98% from $135M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q3 2017 filing shows 33 new, 43 increased, 61 reduced and 33 closed positions. Its largest new stake was Medtronic: 17,182 shares worth $1.34M. The largest sale was Parexel International Corp, an estimated $2.14M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q3 2017 buy was Medtronic: 17,182 shares worth $1.34M.
  • New England Research & Management added most to Carnival Corporation Ltd in Q3 2017, an estimated $839K increase.
  • New England Research & Management's biggest Q3 2017 reduction was Amgen, cutting an estimated $1,000K.
  • New England Research & Management fully exited Parexel International Corp in Q3 2017, selling an estimated $2.14M.
  • New England Research & Management's ten largest holdings make up 22% of its $136M portfolio in Q3 2017.
  • New England Research & Management opened 33 new positions and closed 33 in Q3 2017.
  • New England Research & Management's portfolio value rose 0.98% quarter-over-quarter to $136M.

Based on New England Research & Management's 13F filing for Q3 2017, filed 25 Oct 2017.